Saya Biologics Adopts AI-Powered Document Management System

Saya Biologics has selected Interfacing Technologies Corporation to deploy an AI-powered document control and quality management system. This partnership aims to enhance regulatory compliance and streamline the document lifecycle management for the pharmaceutical company.

The new system will provide Saya Biologics with real-time visibility, version control traceability, and automation across GxP-regulated content and standard operating procedures (SOPs). It will centralize all controlled documents in a secure environment, ensuring they are fully traceable and audit-ready.

Interfacing's platform will also offer AI-driven regulatory intelligence, allowing Saya Biologics to proactively identify and respond to changes in regulatory requirements from agencies such as the FDA, EMA, and Health Canada. This integration is expected to improve operational efficiency by replacing manual workflows with a harmonized system that integrates documentation, processes, training records, and compliance activities.

The decision to partner with Interfacing was influenced by its expertise in regulated industries and its proven success in large-scale digital transformations. This collaboration marks a significant step for Saya Biologics in becoming a fully digital, audit-ready pharmaceutical organization.